Scholarlink

Background <p>The impact of systemic lupus erythematosus (SLE) on total shoulder arthroplasty (TSA) outcomes is unclear. This study investigated the association between SLE and short-term TSA outcomes.</p> Methods <p>Data from the Nationwide Readmission Database (NRD) 2016–2020 of patients ≥ 20&#xa0;years old who underwent primary TSA were included. SLE was identified by International Classification of Diseases, Tenth Revision, and Clinical Modification (ICD-10-CM) codes. Outcomes were compared between patients with and without SLE, and propensity-score matching based on age and sex was performed.</p> Results <p>This study included 1960 matched TSA patients (980 with SLE and 980 without SLE). The mean patient age was 65.7&#xa0;years, and 92% were female. After adjusting for covariates, SLE was significantly associated with a higher risk of surgical complications (odds ratio [OR] = 1.48, 95% confidence interval [CI]: 1.13–1.93), acute postoperative hemorrhagic anemia (OR = 1.48, 95% CI 1.05–2.09), and increased 30-day (OR = 2.11, 95% CI 1.30–3.40) and 90-day (OR = 1.59, 95% CI 1.11–2.26) readmission rates. Patients with SLE with Charlson Comorbidity Index scores of 0 or &gt; 1 had a significantly higher 90-day readmission rate (OR = 2.45 and 1.48, respectively). Additionally, patients with SLE ≥ 65&#xa0;years old had a significantly higher risk of complications (OR = 1.56). Patients with SLE undergoing reverse TSA also exhibited a significantly increased 90-day readmission risk (OR = 1.71).</p> Conclusions <p>SLE significantly increases the risk of postoperative complications and readmissions following TSA, especially in older patients and those undergoing reverse TSA. However, the lack of data on immunosuppressive therapy, laboratory tests, and disease activity may weaken the strength of the evidence.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Impact of systemic lupus erythematosus on adverse outcomes and readmission after total shoulder arthroplasty: a Nationwide Readmission Database analysis 2016–2020

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月21日

查看全文
  • Hao-Ming Chang,
  • Tzu-Hao Wang

摘要

Background

The impact of systemic lupus erythematosus (SLE) on total shoulder arthroplasty (TSA) outcomes is unclear. This study investigated the association between SLE and short-term TSA outcomes.

Methods

Data from the Nationwide Readmission Database (NRD) 2016–2020 of patients ≥ 20 years old who underwent primary TSA were included. SLE was identified by International Classification of Diseases, Tenth Revision, and Clinical Modification (ICD-10-CM) codes. Outcomes were compared between patients with and without SLE, and propensity-score matching based on age and sex was performed.

Results

This study included 1960 matched TSA patients (980 with SLE and 980 without SLE). The mean patient age was 65.7 years, and 92% were female. After adjusting for covariates, SLE was significantly associated with a higher risk of surgical complications (odds ratio [OR] = 1.48, 95% confidence interval [CI]: 1.13–1.93), acute postoperative hemorrhagic anemia (OR = 1.48, 95% CI 1.05–2.09), and increased 30-day (OR = 2.11, 95% CI 1.30–3.40) and 90-day (OR = 1.59, 95% CI 1.11–2.26) readmission rates. Patients with SLE with Charlson Comorbidity Index scores of 0 or > 1 had a significantly higher 90-day readmission rate (OR = 2.45 and 1.48, respectively). Additionally, patients with SLE ≥ 65 years old had a significantly higher risk of complications (OR = 1.56). Patients with SLE undergoing reverse TSA also exhibited a significantly increased 90-day readmission risk (OR = 1.71).

Conclusions

SLE significantly increases the risk of postoperative complications and readmissions following TSA, especially in older patients and those undergoing reverse TSA. However, the lack of data on immunosuppressive therapy, laboratory tests, and disease activity may weaken the strength of the evidence.